Summary
The pharmaceutical industry is unlike any other industry in that the products manufactured can dramatically improve, and even save, lives. This is especially the case when it comes to children. Although pediatric patients comprise a smaller population of pharmaceutical consumers, they have a greater need for products given the paucity of treatment options specifically for them. This two-part paper discusses the need for collaboration across the industry to ensure children get the medicines they need. Download to read Part One or click here to read Part Two.
Register to download
Global Pediatric Drug Development Collaboration Part One
You may also be interested in:
Blog
The RACE for Children Act
In the US, legislation such as the Better Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) have helped to…
Blog
Challenges Arise as the Need for Pediatric Research Increases
Many modern providers prescribe off-label treatment to children with “guesstimated” doses, because these drugs have often only been studied in…
page
The RACE Act
Our team is here to help you prepare for this historic transition in our industry. We’ll be updating this page bi-weekly with need-to-know RACE Act…